ATE282619T1 - Neues verfahren zur herstellung von pyrazolopyrimidonen - Google Patents

Neues verfahren zur herstellung von pyrazolopyrimidonen

Info

Publication number
ATE282619T1
ATE282619T1 AT01936729T AT01936729T ATE282619T1 AT E282619 T1 ATE282619 T1 AT E282619T1 AT 01936729 T AT01936729 T AT 01936729T AT 01936729 T AT01936729 T AT 01936729T AT E282619 T1 ATE282619 T1 AT E282619T1
Authority
AT
Austria
Prior art keywords
pyrazolopyrimidones
producing
new process
new
producing pyrazolopyrimidones
Prior art date
Application number
AT01936729T
Other languages
English (en)
Inventor
Mark Edward Bunnage
Philip Charles Levett
Nicholas Murray Thomson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26244537&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE282619(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0015462A external-priority patent/GB0015462D0/en
Priority claimed from GB0105878A external-priority patent/GB0105878D0/en
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE282619T1 publication Critical patent/ATE282619T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT01936729T 2000-06-22 2001-06-07 Neues verfahren zur herstellung von pyrazolopyrimidonen ATE282619T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0015462A GB0015462D0 (en) 2000-06-22 2000-06-22 Novel process for the preparation of pyrazolopyrimidinones
GB0105878A GB0105878D0 (en) 2001-03-09 2001-03-09 Novel process for the preparation of pyrazoloprimidinones
PCT/IB2001/001038 WO2001098303A1 (en) 2000-06-22 2001-06-07 Novel process for the preparation of pyrazolopyrimidinones

Publications (1)

Publication Number Publication Date
ATE282619T1 true ATE282619T1 (de) 2004-12-15

Family

ID=26244537

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01936729T ATE282619T1 (de) 2000-06-22 2001-06-07 Neues verfahren zur herstellung von pyrazolopyrimidonen

Country Status (25)

Country Link
EP (1) EP1296983B1 (de)
JP (1) JP2004501154A (de)
KR (1) KR100525699B1 (de)
AP (1) AP2001002195A0 (de)
AR (1) AR028729A1 (de)
AT (1) ATE282619T1 (de)
AU (2) AU6259201A (de)
BR (1) BR0111864A (de)
CA (1) CA2411957C (de)
CZ (1) CZ20024130A3 (de)
DE (1) DE60107248T2 (de)
ES (1) ES2231498T3 (de)
GT (2) GT200100113AA (de)
HU (1) HUP0301207A3 (de)
IL (1) IL152983A0 (de)
MX (1) MXPA02012887A (de)
MY (1) MY127737A (de)
PA (1) PA8520001A1 (de)
PE (1) PE20020091A1 (de)
PL (1) PL360299A1 (de)
PT (1) PT1296983E (de)
SV (1) SV2002000502A (de)
TN (1) TNSN01092A1 (de)
WO (1) WO2001098303A1 (de)
YU (1) YU84702A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2310144B1 (es) 2007-06-15 2010-01-12 Galenicum Health, S.L. Intermedios para la preparacion de un inhibidor de la fosfodiesterasa tipo 5.
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
US6087368A (en) * 1998-06-08 2000-07-11 Bristol-Myers Squibb Company Quinazolinone inhibitors of cGMP phosphodiesterase
BR9915532A (pt) * 1998-10-23 2001-08-14 Pfizer Inibidores de cgmp pde5 de pirazolopirimidinona para tratamento da disfunção sexual

Also Published As

Publication number Publication date
BR0111864A (pt) 2003-07-01
YU84702A (sh) 2005-09-19
ES2231498T3 (es) 2005-05-16
CA2411957A1 (en) 2001-12-27
DE60107248D1 (de) 2004-12-23
AP2001002195A0 (en) 2002-12-21
KR100525699B1 (ko) 2005-11-03
HUP0301207A2 (hu) 2003-08-28
AU6259201A (en) 2002-01-02
CZ20024130A3 (cs) 2004-01-14
HUP0301207A3 (en) 2006-02-28
SV2002000502A (es) 2002-07-03
PA8520001A1 (es) 2003-09-05
WO2001098303A1 (en) 2001-12-27
EP1296983A1 (de) 2003-04-02
AU2001262592B2 (en) 2006-07-06
MY127737A (en) 2006-12-29
GT200100113A (es) 2002-06-04
IL152983A0 (en) 2003-06-24
AR028729A1 (es) 2003-05-21
HK1079198A1 (en) 2006-03-31
PT1296983E (pt) 2005-02-28
MXPA02012887A (es) 2003-05-14
GT200100113AA (es) 2006-04-10
DE60107248T2 (de) 2005-12-01
PE20020091A1 (es) 2002-02-21
TNSN01092A1 (fr) 2005-11-10
CA2411957C (en) 2007-09-18
EP1296983B1 (de) 2004-11-17
PL360299A1 (en) 2004-09-06
JP2004501154A (ja) 2004-01-15
KR20030017556A (ko) 2003-03-03

Similar Documents

Publication Publication Date Title
DE60107450D1 (de) Verfahren zur herstellung von fluoroelastomeren
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
AT7110U9 (de) Verfahren zur herstellung von amlodipinmaleat
ATE281447T1 (de) Verfahren zur herstellung von citalopram
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
DE60133118D1 (de) Verfahren zur herstellung von oberflächenelementen
DE60111586D1 (de) Verfahren zur herstellung von optischem material
ATE328885T1 (de) Verfahren zur herstellung von sulfonamid- substituierten imidazotriazinonen
DE60026607D1 (de) Verfahren zur herstellung von perfluoroalkadienen
DE50114795D1 (de) Verfahren zur herstellung von polyisobutenylphenolen
DE50102444D1 (de) Verfahren zur herstellung von isocyanatoorganosilanen
ATE316518T1 (de) Verfahren zur herstellung von (r)-2-alkyl-3- phenyl-1-propanolen
DE60107829D1 (de) Verfahren zur herstellung von flüssigen tensidzusammensetzungen
DE60103173D1 (de) Verfahren zur herstellung von 3-amino-2-chlor-4-methylpyridin
DE50111560D1 (de) Verfahren zur herstellung von guerbetalkoholen
DE60006219D1 (de) Kontinuierliches verfahren zur herstellung von diacetoxybuten
ATE389645T1 (de) Verfahren zur herstellung von citalopram
DE60134415D1 (de) Verfahren zur herstellung von wäscheweichmacherzusammensetzungen
DE60131562D1 (de) Verfahren zur herstellung von benztriazolen
EP1320367A4 (de) Verfahren zur herstellung von dinapsolin
DE50200870D1 (de) Verfahren zur herstellung von hydroxyalkylpolysiloxanen
DE60123013D1 (de) Verfahren zur herstellung von glasskeramiken
DE60105991D1 (de) Verfahren zur herstellung von 6-aminocapronamid
ATE305958T1 (de) Verfahren zur herstellung von waschmitteln

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1296983

Country of ref document: EP

REN Ceased due to non-payment of the annual fee